As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Moderator

W. David Hardy, MD

Adjunct Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; Senior Director of Evidence-Based Practices, Whitman-Walker Health, Washington, DC

Disclosures

Participation by Dr Hardy does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

Disclosure: W. David Hardy, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Theratechnologies Inc.; ViiV Healthcare
Received grants for clinical research from: Amgen Inc.; CytoDyne; Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; ViiV Healthcare

Dr Hardy does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Hardy does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Faculty

Francine Cournos, MD

Professor of Clinical Psychiatry, Mailman School of Public Health, Columbia University, New York, New York

Disclosures

Disclosure: Francine Cournos, MD, has disclosed no relevant financial relationships.

Dr Cournos does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Cournos does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Brian Wells Pence, PhD

Associate Professor, Department of Epidemiology, Gillings School of Public Health, University of North Carolina at Chapel Hill

Disclosures

Disclosure: Brian W. Pence, PhD, MPH, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Merck & Co., Inc.

Dr Pence does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Pence does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Glenn Jordan Treisman, MD, PhD

Professor of Psychiatry and Behavioral Sciences; Director, AIDS Psychiatry Service, Johns Hopkins University School of Medicine, Baltimore, Maryland

Disclosures

Participation by Dr Treisman does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

Disclosure: Glenn J. Treisman, MD, PhD, has disclosed no relevant financial relationships.

Dr Treisman does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Treisman does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

Susan L. Smith, MN, PhD

Lead Scientific Director, Medscape, LLC

Disclosures

Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Robert Morris, PharmD

Associate CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.

CME / ABIM MOC

HIV Treatment and Care: A Focus on Mental Health and Substance Use

Authors: W. David Hardy, MD; Francine Cournos, MD; Brian Wells Pence, PhD; Glenn Jordan Treisman, MD, PhD
CME / ABIM MOC Released: 10/23/2017; Reviewed and Renewed: 3/13/2020
THIS ACTIVITY HAS EXPIRED
Valid for credit through: 3/13/2021

Start Activity

Target Audience and Goal Statement

This activity is intended for physicians and nurses who provide care to patients living with human immunodeficiency virus (HIV) infection.

The goal of this activity is to improve care of patients living with HIV who also have mental health and/or substance use disorders.

Upon completion of this activity, participants will:

Have increased knowledge regarding the:
- Mental health disorders and substance use as risk factors for nonadherence to antiretroviral therapy
- Unique challenges faced by patients living with HIV who experience mental health disorders and/or substance use
- Strategies for screening and addressing factors related to mental health disorders and substance use during HIV treatment and care
- Clinical benefits of including assessment for mental health disorders and substance use in the routine medical care of patients living with HIV

Disclosures

Moderator

W. David Hardy, MD

Adjunct Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; Senior Director of Evidence-Based Practices, Whitman-Walker Health, Washington, DC

Disclosures

Participation by Dr Hardy does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

Disclosure: W. David Hardy, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Theratechnologies Inc.; ViiV Healthcare
Received grants for clinical research from: Amgen Inc.; CytoDyne; Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; ViiV Healthcare

Dr Hardy does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Hardy does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Faculty

Francine Cournos, MD

Professor of Clinical Psychiatry, Mailman School of Public Health, Columbia University, New York, New York

Disclosures

Disclosure: Francine Cournos, MD, has disclosed no relevant financial relationships.

Dr Cournos does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Cournos does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Brian Wells Pence, PhD

Associate Professor, Department of Epidemiology, Gillings School of Public Health, University of North Carolina at Chapel Hill

Disclosures

Disclosure: Brian W. Pence, PhD, MPH, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Merck & Co., Inc.

Dr Pence does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Pence does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Glenn Jordan Treisman, MD, PhD

Professor of Psychiatry and Behavioral Sciences; Director, AIDS Psychiatry Service, Johns Hopkins University School of Medicine, Baltimore, Maryland

Disclosures

Participation by Dr Treisman does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

Disclosure: Glenn J. Treisman, MD, PhD, has disclosed no relevant financial relationships.

Dr Treisman does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Treisman does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor

Susan L. Smith, MN, PhD

Lead Scientific Director, Medscape, LLC

Disclosures

Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

CME Reviewer(s)

Robert Morris, PharmD

Associate CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Family Medicine

CME / ABIM MOC

HIV Treatment and Care: A Focus on Mental Health and Substance Use

Authors: W. David Hardy, MD; Francine Cournos, MD; Brian Wells Pence, PhD; Glenn Jordan Treisman, MD, PhDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 10/23/2017; Reviewed and Renewed: 3/13/2020

Valid for credit through: 3/13/2021

processing....

Page 1 of 7

CME / ABIM MOC Information Download Slides

CME Information

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Faculty and Disclosures

Moderator

W. David Hardy, MD

Faculty

Francine Cournos, MD

Brian Wells Pence, PhD

Glenn Jordan Treisman, MD, PhD

Editor

Susan L. Smith, MN, PhD

CME Reviewer(s)

Robert Morris, PharmD

CME / ABIM MOC

HIV Treatment and Care: A Focus on Mental Health and Substance Use

Target Audience and Goal Statement

Disclosures

Moderator

W. David Hardy, MD

Faculty

Francine Cournos, MD

Brian Wells Pence, PhD

Glenn Jordan Treisman, MD, PhD

Editor

Susan L. Smith, MN, PhD

CME Reviewer(s)

Robert Morris, PharmD

Accreditation Statements

For Physicians

Instructions for Participation and Credit

HIV Treatment and Care: A Focus on Mental Health and Substance Use